BABY Share Price

Open 37.45 Change Price %
High 38.15 1 Day 0.15 0.40
Low 37.25 1 Week -0.20 -0.52
Close 37.95 1 Month -1.15 -2.94
Volume 143435 1 Year 0.74 1.99
52 Week High 44.39
52 Week Low 29.54
BABY Important Levels
Resistance 2 38.78
Resistance 1 38.44
Pivot 37.78
Support 1 37.46
Support 2 37.12
NASDAQ USA Most Active Stocks
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
RIMM 13.03 0.39%
BBEP 0.12 0.00%
GTAT 0.44 0.00%
SUSQ 14.20 -0.77%
ACAS 17.99 0.39%
ASTI 0.00 0.00%
WRES 0.09 28.57%
NASDAQ USA Top Gainers Stocks
MYRX 0.10 100.00%
LOCM 0.09 50.00%
CEMP 4.05 28.57%
WRES 0.09 28.57%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
OTT 2.39 25.13%
SKBI 0.10 25.00%
IPCI 2.55 18.60%
QKLS 0.15 15.38%
NASDAQ USA Top Losers Stocks
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
GMETP 0.70 -59.54%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
EDMC 0.01 -50.00%
QTWW 0.08 -50.00%
SPIR 0.01 -50.00%
OSH 0.26 -49.02%
OSH 0.26 -49.02%

Natus Medical Incorporated (NASDAQ: BABY)

BABY Technical Analysis 3
As on 24th Feb 2017 BABY Share Price closed @ 37.95 and we RECOMMEND Buy for LONG-TERM with Stoploss of 37.50 & Buy for SHORT-TERM with Stoploss of 36.87 we also expect STOCK to react on Following IMPORTANT LEVELS.
BABY Target for February
1st Target up-side 41.78
2nd Target up-side 43.69
3rd Target up-side 45.6
1st Target down-side 36.33
2nd Target down-side 34.42
3rd Target down-side 32.51
BABY Other Details
Segment EQ
Market Capital 360599776.00
Sector Healthcare
Industry Medical Appliances & Equipment
Offical website
BABY Address
1501 Industrial Road
San Carlos, CA 94070
United States
Phone: 650-802-0400
Fax: 650-802-0401
BABY Latest News
Natus Medical Inc Hears a Bright 2017   Motley Fool   - 03rd Feb 17
Natus Medical Incorporated in 4 Charts   Motley Fool   - 05th Dec 16
Natus Medical Inc.: This BABY Keeps Chugging Along   Motley Fool   - 20th Oct 16
Why Natus Medical Inc Slipped Today   Motley Fool   - 26th Sep 16
How Natus Medical Inc. Got Back on Track   Motley Fool   - 21st Jul 16
3 Things to Watch As Natus Medical Inc Reports Earnings   Motley Fool   - 19th Jul 16
Natus Medical Inc Says Adios to Venezuela Guidance   Motley Fool   - 21st Apr 16
Why Natus Medical Inc. Reported Lower Today   Motley Fool   - 04th Apr 16
Natus Medical Inc. Serving Up Earning Growth   Motley Fool   - 28th Jan 16
Natus Medical Inc. Serves Up a New Business Model   Motley Fool   - 29th Jan 15
Interactive Technical Analysis Chart Natus Medical Incorporated ( BABY NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from
Your Comments and Response on Natus Medical Incorporated
BABY Business Profile
Natus Medical Incorporated (Natus), incorporated in May 1987, is a provider of healthcare products used for the screening, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, and balance and mobility disorders. The Company’s product offerings include computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology, as well as newborn care products, such as hearing screening systems, phototherapy devices for the treatment of newborn jaundice, head-cooling products for the treatment of brain injury in newborns, incubators to control the newborn’s environment, and software systems for managing and tracking disorders and diseases for public health laboratories. Natus categorizes its products into three categories: Hearing, Neurology and Newborn Care. On September 15, 2011, it acquired Embla Systems LLC. In July 2012, the Company acquired the Nicolet neurodiagnostic business from CareFusion. Hearing includes products for newborn hearing screening and diagnostic hearing assessment. The Company’s newborn hearing screening techniques consists of auditory brainstem response (ABR) and otoacoustic emission (OAE). Its newborn hearing screening product lines consist of the ALGO, ABaer, AuDX and Echo-Screen newborn hearing screeners. These hearing screening products utilize signal detection technologies to provide non-invasive hearing screening for newborns and are designed to detect hearing loss at 35 decibel above normal adult hearing level (dB nHL) or higher. Its AABR devices deliver thousands of soft audible clicks to the newborn’s ears through sound cables and disposable earphones connected to the instrument. Each click elicits an identifiable brain wave, which is detected by disposable electrodes placed on the head of the child and analyzed by the screening device. These devices use its AABR signal detection algorithm. The Company’s ABaer, which is a personal computer (PC)-based newborn hearing screening device, offers a combination of AABR, OAE, and diagnostic auditory brainstem response (ABR) technologies in one system. The automatic ABR technology utilizes its point optimized variance ratio (POVR) signal detection algorithm developed by the House Ear Institute. Like its ALGO newborn hearing screeners, this device delivers thousands of soft audible clicks to the newborn’s ears through sound cables and disposable earphones. Each click elicits an identifiable brain wave, which is detected by disposable electrodes placed on the head of the child and analyzed by the screening device.